Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation
Globenewswire· 2025-09-29 12:00
CHICAGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its Chief Executive Officer, Greg Siokas, has issued the following letter to the Company’s shareholders. Dear Fellow Shareholders, Cosmos Health stands at a defining moment in its journey. Over the past year, we have made decisive progress - refining our strategy, reinforcing our operations, and positioning every b ...
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium
Globenewswire· 2025-09-29 12:00
ROCKAWAY, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCore™ Sapphire (nVNS) has been included in a long-term reimbursement policy launched by the National Institute for Health and Disability Insurance (RIZIV / INAMI) in Belgium. Effective October 1, 2025, the policy provides coverage for gammaCore Sapphire to treat patients with cluster headaches. This coverage is based on strong clinical ...
Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston
Globenewswire· 2025-09-29 12:00
SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, today announced that its management will participate in the second annual Oncology Venture, Innovation, and Partnering Summit being held September 29-30, 2025, at the Westin Boston Seaport in Boston, MA. Eric Poma, Ph.D., ...
MBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic Forum
Globenewswire· 2025-09-29 12:00
CARMEL, Ind., Sept. 29, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, and Sam Azoulay, MD, Chief Medical Officer, will participate in a fireside chat at the Stifel 2025 Virtual Cardiometabolic Forum on September 30. Stifel 2025 Virtual Cardiome ...
VVC – Commencement of Central Kansas Uplift Project
Globenewswire· 2025-09-29 12:00
TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- VVC Exploration Corporation, dba VVC Resources ("VVC" or the "Company") (TSX-V: VVC; OTC: VVCVF) today announces its strategic development of the Central Kansas Uplift ("CKU") Project, an initiative being advanced through VVC’s wholly owned subsidiary, Plateau Helium Corporation ("PHC"). The CKU Project targets helium-rich natural gas within multiple stacked reservoirs in Rush and Pawnee Counties, Kansas, where PHC has assembled a meaningful lease position and ide ...
Apyx Medical to Host Virtual Key Opinion Leader Event to Discuss the Commercial Launch of The AYON Body Contouring System™ on October 14, 2025
Globenewswire· 2025-09-29 12:00
CLEARWATER, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that it will host a virtual key opinion leader (KOL) event on Tuesday, October 14, 2025 at 12:00 PM ET featuring Paul Vanek, Jr., MD, FACS (Founder, President & CEO, Mentor Plastic Surgery & MedSpa), who will join company ma ...
CareCloud Announces Acquisition of HFMA’s MAP App to Expand AI-Driven Benchmarking in Hospitals and Integrated Health Systems
Globenewswire· 2025-09-29 12:00
Acquisition and long-term partnership with HFMA further strengthen CareCloud’s position in the inpatient healthcare IT market SOMERSET, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-driven healthcare technology solutions for hospitals, integrated health systems, and medical practices nationwide, today announced its definitive agreement to acquire MAP App, a leading hospital benchmarking tool created by the Healthcare Financial M ...
HF Foods Group Announces Agreement to Acquire Chicago Distribution Facility
Globenewswire· 2025-09-29 12:00
Strategic development expected to reduce facility costs, expand capacity and support long-term growth Acquisition follows HF Foods’ establishment of an At-the-Market equity offering program to provide liquidity for, among other items, capital expenditures, and possible acquisitions or business expansion LAS VEGAS, Sept. 29, 2025 (GLOBE NEWSWIRE) -- HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods” or the “Company”), a leading distributor of international foodservice solutions to Asian restaurants and other bus ...
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal
Globenewswire· 2025-09-29 12:00
Boca Raton, FL, Sept. 29, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces the submission of a manuscript detailing the results of its Phase 2 MINDFuL trial. The manuscript, titled, “XPro1595, a Selective Soluble TNF Neutralizer, in Early Alzheimer’s Disease with Inflammation (ADi): Results from the Phase 2 MINDFuL Trial,” has been submitted for peer review to npj Dementia, a Nature Portfolio journal. The detailed manuscript prov ...
The Oncology Institute Partners with Protocol Behavioral Health to Integrate Mental Health Services into Cancer Care
Globenewswire· 2025-09-29 12:00
CERRITOS, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI), a pioneer in value-based community oncology care, is pleased to announce a new partnership with Protocol Behavioral Health, a leading provider of evidence-based mental health care for cancer patients. This collaboration underscores TOI’s commitment to delivering whole-person care by integrating behavioral health services directly into the cancer care journey. Research shows that approximately 30% of cancer patients ex ...